Skip to main content

Find Clinical Trials

Home
Conditions
Hormone Receptor Positive / HER2-negative Breast Cancer

Clinical trial condition

Hormone Receptor Positive / HER2-negative Breast Cancer

Explore clinical trials studying Hormone Receptor Positive / HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Hormone Receptor Positive / HER2-negative Breast Cancer trial results

Not Yet Recruiting

A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.

NCT07619066

Conditions: Advanced Breast Cancer, HER2 Mutation, Hormone Receptor Positive / HER2-negative Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

NCT07101159

Conditions: Adjuvant Therapy, Breast Diseases, Breast Neoplasms, +6 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

NCT04802876

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +111 more
Locations: Grupo SOLTI Barcelona, Spain

View Trial Details